These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 38940671)
41. Double faced role of human mesenchymal stem cells and their role challenges in cancer therapy. Serakinci N; Kalkan R; Tulay P Curr Stem Cell Res Ther; 2016; 11(4):343-51. PubMed ID: 26832140 [TBL] [Abstract][Full Text] [Related]
42. Impact of cellular senescence in aging and cancer. Provinciali M; Cardelli M; Marchegiani F; Pierpaoli E Curr Pharm Des; 2013; 19(9):1699-709. PubMed ID: 23061727 [TBL] [Abstract][Full Text] [Related]
43. ATOH8 binds SMAD3 to induce cellular senescence and prevent Ras-driven malignant transformation. Liu X; Li X; Wang S; Liu Q; Feng X; Wang W; Huang Z; Huang Y; Wu J; Cai M; Cai X; Xu X; Cai J; Li M Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2208927120. PubMed ID: 36626550 [TBL] [Abstract][Full Text] [Related]
44. A Nexus model of cellular transition in cancer. Yadav M; Chatterjee P; Tolani S; Kulkarni J; Mulye M; Chauhan N; Sakhi A; Gorey S Biol Res; 2018 Aug; 51(1):23. PubMed ID: 30086794 [TBL] [Abstract][Full Text] [Related]
45. Summation and synthesis: from the cancer cell biology point of view. Stanbridge EJ Adv Exp Med Biol; 1993; 330():307-14. PubMed ID: 8368139 [No Abstract] [Full Text] [Related]
46. Telomeres and senescence: ending the debate. de Lange T Science; 1998 Jan; 279(5349):334-5. PubMed ID: 9454329 [No Abstract] [Full Text] [Related]
47. SATB1, senescence and senescence-related diseases. Qi W; Bai J; Wang R; Zeng X; Zhang L J Cell Physiol; 2024 Aug; 239(8):e31327. PubMed ID: 38801120 [TBL] [Abstract][Full Text] [Related]
49. Proliferative cell senescence, transformation, and the recombination potential of the genome. Macieira-Coelho A Exp Gerontol; 1996; 31(1-2):227-34. PubMed ID: 8706792 [TBL] [Abstract][Full Text] [Related]
50. Oncogene-induced senescence: a potential breakpoint mechanism against malignant transformation in plasma cell disorders. Lehners N; Ellert E; Xu J; Hillengass J; Leichsenring J; Stenzinger A; Goldschmidt H; Andrulis M; Raab MS Leuk Lymphoma; 2018 Nov; 59(11):2660-2669. PubMed ID: 29616856 [TBL] [Abstract][Full Text] [Related]
51. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence. Barnoud T; Schmidt ML; Donninger H; Clark GJ Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242 [TBL] [Abstract][Full Text] [Related]
52. Two-Step Senescence-Focused Cancer Therapies. Sieben CJ; Sturmlechner I; van de Sluis B; van Deursen JM Trends Cell Biol; 2018 Sep; 28(9):723-737. PubMed ID: 29776716 [TBL] [Abstract][Full Text] [Related]
53. Cellular senescence, an unpopular yet trustworthy tumor suppressor mechanism. Ishikawa F Cancer Sci; 2003 Nov; 94(11):944-7. PubMed ID: 14611669 [TBL] [Abstract][Full Text] [Related]
54. Tetraploidy as a metastable state towards malignant cell transformation within a systemic approach of cancer development. Kirsch-Volders M; Mišík M; de Gerlache J Mutat Res Genet Toxicol Environ Mutagen; 2024; 896():503764. PubMed ID: 38821671 [TBL] [Abstract][Full Text] [Related]
55. p53/MDM2 signaling pathway in aging, senescence and tumorigenesis. Huang Y; Che X; Wang PW; Qu X Semin Cancer Biol; 2024 Jun; 101():44-57. PubMed ID: 38762096 [TBL] [Abstract][Full Text] [Related]